COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

CARDIOVASCULAR RESEARCH FOUNDATION

NEW YORK, NY · EIN 521752653 · Form 990 · FY2024 · NTEE H20Z · Medical Research · Very Large (>$50M) · crf.org
revenue
$68.9M
expenses
$66.7M
net assets
$50.2M
employees
213
volunteers
10
program ratio
88%
mission · from form 990

CARDIOVASCULAR RESEARCH FOUNDATION IS AN INDEPENDENT, ACADEMICALLY FOCUSED ORGANIZATION DEDICATED TO IMPROVING THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH RESEARCH AND EDUCATION. THE ORGANIZATION HAS PLAYED A MAJOR ROLE IN REALIZING DRAMATIC IMPROVEMENTS IN THE LIVES OF COUNTLESS NUMBERS OF PATIENTS BY ESTABLISHING THE SAFE USE OF NEW TECHNOLOGIES AND THERAPIES IN THE SUBSPECIALTY OF INTERVENTIONAL CARDIOLOGY AND ENDOVASCULAR MEDICINE.

profile · synthesized from sources

The Cardiovascular Research Foundation is an independent, academically focused nonprofit dedicated to improving survival and quality of life for people with cardiovascular disease through research and education. It advances new technologies and therapies in interventional cardiology and endovascular medicine via preclinical research, clinical trials, and global educational initiatives, including the Transcatheter Cardiovascular Therapeutics (TCT) meeting.

irs program accomplishments · form 990 part iii · fy2024

What they reported doing

  1. #1 primary $6.29M
    SKIRBALL CENTER FOR INNOVATION - A STATE OF THE ART INNOVATION CENTER, THE CRF SKIRBALL CENTER FOR INNOVATION IS DEDICATED TO THE INVESTIGATION AND VALIDATION OF NOVEL CONCEPTS, TREATMENTS, AND DEVICES. OUR PREEMINENT TEAM OF PIONEERING RESEARCHERS AND THOUGHT LEADERS CONTINUALLY BREAK NEW GROUND AS THEY GUIDE EARLY IDEAS AND INVENTIONS THROUGH COMPREHENSIVE PRECLINICAL RESEARCH PROGRAMS TO INTRODUCE PRACTICAL THERAPIES INTO CLINICAL MEDICINE.
  2. #2 $10.84M
    TCT 2024 (TRANSCATHETER CARDIOVASCULAR THERAPEUTICS) MEETING - THE CARDIOVASCULAR RESEARCH FOUNDATION (CRF) STANDS AT THE FOREFRONT OF EDUCATION IN CARDIOVASCULAR MEDICINE. THIS FOCUS REFLECTS THE CRF FACULTY'S COMMITMENT TO SHARING AND DISSEMINATING THE LATEST CLINICAL RESEARCH INFORMATION TO THE BROADEST AUDIENCE AT THE EARLIEST POSSIBLE DATE. THE FUNDAMENTAL GOAL OF CRF'S EDUCATION PROGRAM IS TO ENABLE THE GLOBAL PHYSICIAN COMMUNITY TO APPLY IMPORTANT NEW KNOWLEDGE TO ACTUAL PATIENT CARE. CRF'S PRINCIPAL ANNUAL EDUCATIONAL EVENT, TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT) MEETING, IS THE WORLD'S LARGEST EDUCATIONAL MEETING DEDICATED TO THE FIELD OF INTERVENTIONAL VASCULAR THERAPY. THIS IS THE SHOWCASE EDUCATIONAL EVENT IN THE CARDIOVASCULAR FIELD AND IS USED TO EDUCATE AND EXCHANGE STUDY FINDINGS AND TO IMPROVE TREATMENT OF PATIENTS WHO HAVE CARDIOVASCULAR DISEASE.
named programs · 4 · from sources

What they call their work

CRF Clinical Trials Center
Conducts and manages clinical trials, core laboratory analyses, and cardiovascular imaging research to support evidence-based advancements in cardiovascular therapies
CRF Digital
Oversees digital platforms including TCTMD and CRF Connect, providing news, on-demand education, and professional community engagement for cardiovascular specialists worldwide
CRF Skirball Center for Innovation
State-of-the-art innovation center focused on preclinical research and validation of novel cardiovascular devices, treatments, and technologies to advance clinical adoption
TCT (Transcatheter Cardiovascular Therapeutics) Meeting
World's largest educational meeting dedicated to interventional vascular therapy, serving as a global forum for disseminating clinical research and improving patient care
activities · 3 groups

What they do

  • Biomedical Research and Innovation 3 activities
    • Advances cardiovascular technology and innovation
      Leads in the development and refinement of transcatheter therapies and imaging technologies, including pioneering procedures such as mitral balloon valvuloplasty and co-developing the PS3 system. Manages an innovation program focused on advancing medical device development and simulates ventricular mechanics using the Harvi platform.
    • Conducts preclinical and clinical cardiovascular research
      Identifies, develops, and validates novel therapies and devices for heart and vascular disease through preclinical research programs at the Skirball Center for Innovation and by leading first-in-man, multicenter, and international clinical trials. The organization has participated in over 700 clinical trials involving more than 200,000 patients and has served as national principal investigator in key studies such as PARTNER, SCOUT, and Triscend II Pivotal Trial.
    • Publishes and disseminates cardiovascular research findings
      Produces high-impact academic output including peer-reviewed manuscripts, conference presentations, and sponsored publications. Authors have published over 500 to nearly 2,000 scientific papers collectively, including from major trials like HORIZONS-AMI and PARTNER I/II, in journals such as The New England Journal of Medicine, JAMA, and The Lancet.
  • Medical Professional Education & Training 2 activities
    • Hosts major educational conferences for cardiovascular professionals
      Organizes large-scale, annual educational events including the Transcatheter Cardiovascular Therapeutics (TCT) symposium, New York Valves, LAAC Summit, and Technology and Heart Failure Therapeutics (THT) conference to advance clinical knowledge and disseminate research findings to interventional cardiologists and structural heart specialists globally.
    • Provides training and leadership development for cardiovascular clinicians
      Trains physicians, fellows, and medical students through structured fellowship programs, simulation-based learning with Harvi, and global curricula in interventional cardiology and structural heart disease. Offers ongoing professional development via the CRF Fellows Course, State-of-the-Art Echo Course, grand rounds lectures, and international speaking engagements.
  • Disease-Specific Clinical & Patient Education 1 activity
    • Provides public and professional education on heart health
      Offers educational initiatives to both the medical community and the general public, including the Women's Heart Health Initiative that teaches women strategies to reduce cardiovascular risk, and digital platforms like TCTMD and CRF Connect for professional engagement and learning.
financials · form 990 · fy2024
revenue
Total revenue$68.90M
Contributions & grants$7.42M11%
Program service revenue$59.96M87%
Investment income$1.65M2%
Other revenue$-127K
expenses
Total expenses$66.66M
Program expenses88%
Admin / overhead12%
Fundraising0%
Salaries & benefits$26.82M
Grants paid out$1.00M
Largest expense lineCompensation
balance sheet
Total assets$87.49M
Cash$21.38M
Investments$24.39M
Liabilities$37.25M
Net assets$50.24M
Liquid reserves8.2 mo
4 years on record · 2020–2024 · YoY revenue -12.0%
leadership · form 990 part vii · fy2024

Who runs it

paid leadership · 8
NameTitleHours/wkCompensation
JUAN F GRANADA MD CEO & DIRECTOR 38 $1.00M
DAVID COHEN DIRECTOR OF CLINICAL & OUT 38 $737K
EILEEN MORALES CFO 38 $514K
DONALD L ABRAMS CHIEF LEGAL OFFICER 38 $510K
ALEXANDRA POPMA DIRECTOR 38 $485K
TRICIA RAWH EXECUTIVE DIRECTOR, CED 38 $454K
GRZEGORZ KALUZA DIRECTOR RESEARCH 38 $392K
DANIEL BURKOFF DIRECTOR OF HEART FAILURE 38 $372K
board members · 10
  • COLETTE Y GARDNER — DIRECTOR
  • ERIC B WOLDENBERG — CHAIRMAN
  • FRANK LITVACK MD — DIRECTOR
  • JEFFREY W MOSES MD — DIRECTOR
  • JOSEPH G BECK — DIRECTOR
  • KAREN G KRASNEY — DIRECTOR
  • MARTIN B LEON MD — DIRECTOR
  • MARVIN L WOODALL — DIRECTOR
  • TERESA LESTE — DIRECTOR
  • WILLIAM A HIMMELSBACH — DIRECTOR
relationships · 34

Who they work with

  • Academic Research Consortium Partner — Contributed to writing committees for four clinical research documents.
  • American Society of Echocardiography Partner — Collaborates on clinical guidelines and educational programming, including the State-of-the-Art Echo Course.
  • Beth Israel Deaconess Medical Center Partner — Previous institutional affiliation for key leadership and collaborative research
  • Brigham and Women’s Hospital Partner — Previous institutional affiliation for key leadership
  • CRF IVI Core Lab Partner — Core laboratory analyzing NIRS imaging for lipid core-containing plaque in multiple studies.
  • Capricor Therapeutics, Inc. Partner — Shares leadership with CRF, including roles held by Karen G. Krasney and Frank Litvack.
  • Columbia University Partner — Collaborates on heart failure research and educational initiatives
  • Columbia University Irving Medical Center Partner — Collaborates with CRF through shared leadership and research initiatives in cardiovascular medicine.
  • Columbia University Irving Medical Center Partner — Hosts joint clinical and research programs through the Columbia Structural Heart & Valve Center.
  • Consortium of Latin-American Investigators of New Interventions in Cardiology Network — Served as president; advanced research and innovation in interventional cardiology across Latin America.
  • Erasmus University Partner — Collaborates with CRF through shared academic leadership and research in interventional cardiology.
  • Guidestar Network — Profile listed on Guidestar, a nonprofit transparency and information network.
  • Harvard Medical School Partner — Academic affiliation for faculty members and research collaboration
  • Harvard Medical School Partner — Professor of medicine and completed advanced training; earned master’s degree in 2013.
  • Jacob K. Javits Convention Center Partner — Host venue for the New York Valves conference.
  • Johnson & Johnson Interventional Systems Company Partner — Collaborates through shared leadership history and development of key cardiovascular devices such as the Palmaz-Schatz and Cypher stents.
  • Latin American Society for Interventional Cardiology Network — Founding member; helped establish interventional cardiology clinical trials across Latin America.
  • Massachusetts General Hospital Partner — Long-term affiliation as director of the Knight Cardiac Catheterization Laboratory and leader of clinical trial selection and fellowship training programs.
  • Medical University of South Carolina (MUSC) Partner — Collaborates through shared leadership and research development via the Zucker Institute of Applied Neurosciences and Foundation for Research Development.
  • NewYork-Presbyterian Partner — Collaborates on structural heart and valve care through the Columbia Structural Heart & Valve Center.
  • NewYork-Presbyterian Hospital Partner — Collaborates with CRF through shared clinical and research leadership in interventional cardiology.
  • Skirball Center for Innovation Partner — Collaborative innovation center focused on validating novel cardiovascular treatments and devices.
  • St. Francis Hospital & Heart Center Partner — Collaborates on academic affairs and clinical research initiatives
  • TCTMD Network — Operates TCTMD as a media and education platform for interventional cardiovascular therapeutics.
  • The Baim Institute for Clinical Research Partner — Professional affiliation and collaboration in clinical trials research
  • The Johns Hopkins School of Medicine Partner — Alumni and research affiliation for faculty members
  • Thoraxcenter at Erasmus University Medical Center Partner — Collaborates with CRF through shared expertise in interventional cardiology and clinical research.
  • Transcatheter Cardiovascular Therapeutics Network — Annual scientific symposium organized by the Cardiovascular Research Foundation
  • Transcatheter Cardiovascular Therapeutics Partner — Hosts the annual TCT scientific symposium as part of its educational programming.
  • University of California, Davis Partner — Collaborated with the Cardiac Catheterization Laboratory at UC Davis to co-develop the percutaneous septal sinus shortening (PS3) system.
+ 4 more
strategies · 4

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Clinician-Led Innovation and Mentorship Model
    methodology: mentorship-driven_capacity_building
    By placing expert physicians at the center of research, education, and mentorship, we advance interventional cardiology and build global capacity because hands-on training and leadership development produce higher fidelity adoption of complex techniques than passive learning alone.
  • Integrated Research-to-Practice Continuum
    methodology: research_continuum_acceleration
    By integrating innovation, clinical research, physician education, and real-world evidence across the full research continuum, we accelerate the delivery of breakthrough cardiovascular therapies to patients because siloed approaches slow adoption and limit impact.
  • Interdisciplinary Translational Innovation
    methodology: interdisciplinary_innovation
    By integrating medicine, engineering, AI, data science, and entrepreneurship, we translate early-stage innovations into clinical practice more effectively because cross-domain collaboration drives faster, scalable solutions that single-discipline efforts cannot achieve.
  • Rapid Knowledge Dissemination for Clinical Impact
    methodology: research-to-practice_translation
    By rapidly disseminating late-breaking research and innovative clinical findings through digital platforms and global education, we directly influence clinical practice and standards of care because timely access to evidence enables faster adoption and improved patient outcomes.